Company

Nine Square Therapeutics, Inc.

Nine Square Therapeutics, Inc. of South San Francisco develops therapeutics for neurodegenerative diseases such as Alzheimer's and Parkinson's.

About

Founded in 2020 by Matt Jacobson and Steve Altschuler and headquartered in South San Francisco, US, Nine Square Therapeutics develops drugs for neurodegenerative diseases through drug discovery platforms aimed at previously considered undruggable targets. On September 12, 2023 it received a USD 4.5 mn grant from the Michael J. Fox Foundation to support its Parkinson's disease therapy. Robert Paul is CEO.

3Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in